Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles

MLA

Fei-long Jiang, et al. “Identification and Imaging of MiR-155 in the Early Screening of Lung Cancer by Targeted Delivery of Octreotide-Conjugated Chitosan-Molecular Beacon Nanoparticles.” Drug Delivery, vol. 25, Jan. 2018, pp. 1974–83. EBSCOhost, https://doi.org/10.1080/10717544.2018.1516003.

APA

Fei-long Jiang, Guo Yi, Zhengtang Chen, Guang-Peng Chen, Xiu-Feng Pang, Hou Jing, Hai-Zhen Zhu, Jianguo Sun, & Liu Xin. (2018). Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles. Drug Delivery, 25, 1974–1983. https://doi.org/10.1080/10717544.2018.1516003

Chicago

Fei-long Jiang, Guo Yi, Zhengtang Chen, Guang-Peng Chen, Xiu-Feng Pang, Hou Jing, Hai-Zhen Zhu, Jianguo Sun, and Liu Xin. 2018. “Identification and Imaging of MiR-155 in the Early Screening of Lung Cancer by Targeted Delivery of Octreotide-Conjugated Chitosan-Molecular Beacon Nanoparticles.” Drug Delivery 25 (January): 1974–83. doi:10.1080/10717544.2018.1516003.